Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps.

Umberto TanziniAndrea RampiAlessandro VinciguerraGiulia DanèMona Rita YacoubMario BussiMatteo Trimarchi

Published in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2024)

dupilumab provides an excellent long-term control of CRSwNP, but the response in asthmatic and atopic patients appears to be different and delayed when compared to non asthmatic and non atopic ones.

Keyphrases

chronic rhinosinusitis
atopic dermatitis
end stage renal disease
lung function
chronic kidney disease
newly diagnosed
peritoneal dialysis
prognostic factors
chronic obstructive pulmonary disease
air pollution